General Information of the Compound
Compound ID |
CP0423346
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-cyclohexyl-2-(3,5-dimethylpyrazol-1-yl)-6-methylpyrimidin-4-amine
Show/Hide
|
||||||||||||||||||
Synonyms |
73029-73-9
AC1LIR5Q
BDBM50275157
C16H23N5
CHEMBL453730
CTK8F8875
CyPPA
CyPPA, >
DTXSID20358676
GTPL2323
HMS3262M15
MFCD01550586
MolPort-000-762-862
N-cyclohexyl-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4-amine
N-cyclohexyl-2-(3,5-dimethylpyrazol-1-yl)-6-methylpyrimidin-4-amine
SCHEMBL3233745
STK052676
Tox21_500707
USEMRPYUFJNFQN-UHFFFAOYSA-N
ZINC492516
cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H23N5
|
||||||||||||||||||
Molecular Weight |
285.395
|
||||||||||||||||||
Canonical SMILES |
Cc1cc(C)n(n1)-c1nc(C)cc(NC2CCCCC2)n1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H23N5/c1-11-10-15(18-14-7-5-4-6-8-14)19-16(17-11)21-13(3)9-12(2)20-21/h9-10,14H,4-8H2,1-3H3,(H,17,18,19)
Show/Hide
|
||||||||||||||||||
InChIKey |
USEMRPYUFJNFQN-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06093, Small conductance calcium-activated potassium channel protein 2
Protein ID: PT02468, Small conductance calcium-activated potassium channel protein 3
Clinical Information about the Compound